Literature DB >> 16738495

Reliability of two-dimensional echocardiography in the assessment of clinically significant abnormal hemidiaphragm motion in pediatric cardiothoracic patients: Comparison with fluoroscopy.

Stephen G Miller1, Michael M Brook, Theresa A Tacy.   

Abstract

OBJECTIVE: To assess the utility and reliability of echocardiographic assessment of hemidiaphragm motion abnormalities in pediatric cardiothoracic patients.
DESIGN: Retrospective observational study, with post hoc blinded assessment of echocardiographic and fluoroscopic results.
SETTING: Tertiary care center. PATIENTS: Thirty-six consecutive pediatric cardiothoracic patients with suspected hemidiaphragm paralysis were identified and included in the study.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The results of both echocardiographic and fluoroscopic studies on all patients were included. In addition, blinded review of study results were performed. The sensitivity and specificity of fluoroscopy in identifying hemidiaphragms that needed plication were 100% and 74%, respectively. The positive predictive value was 55%; negative predictive value was 100%. Comparing reported diagnoses with blinded review of the studies showed poor agreement; reviewers agreed with 89% diagnosed as normal, 44% of paralyzed, and 76% of paradoxical hemidiaphragms. The sensitivity and specificity of echo in identifying hemidiaphragms that needed plication were 100% and 81%, respectively. The positive predictive value and negative predictive value were 66% and 100%. Comparing reported diagnoses with blinded review, reviewers agreed with 97% diagnosed as normal, 81% of paralyzed, and 100% of paradoxical hemidiaphragms. Echocardiography was less accurate in discriminating between paralyzed and paradoxical diaphragm motion. Echocardiography was specific for paradoxical motion, since both patients identified by echocardiography were confirmed by fluoroscopy, but it was not sensitive. In nine patients, echo showed paralyzed motion that was identified by fluoroscopy as paradoxical.
CONCLUSIONS: This study supports the use of echocardiography in the assessment of diaphragm function. When the diaphragms are clearly visualized by echo, as they are in the majority of cases, the addition of an additional fluoroscopic study adds no clinical value. The differentiation between paralyzed and paradoxical motion is unreliable by both imaging modalities.

Entities:  

Mesh:

Year:  2006        PMID: 16738495     DOI: 10.1097/01.PCC.0000227593.63141.36

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  5 in total

Review 1.  Neuromuscular ultrasound for evaluation of the diaphragm.

Authors:  Aarti Sarwal; Francis O Walker; Michael S Cartwright
Journal:  Muscle Nerve       Date:  2013-02-04       Impact factor: 3.217

2.  Diaphragmatic palsy after cardiac surgical procedures in patients with congenital heart.

Authors:  Sachin Talwar; Sandeep Agarwala; Chander Mohan Mittal; Shiv Kumar Choudhary; Balram Airan
Journal:  Ann Pediatr Cardiol       Date:  2010-01

3.  Sensitivity and specificity of diagnostic ultrasound in the diagnosis of phrenic neuropathy.

Authors:  Andrea J Boon; Hiroshi Sekiguchi; Caitlin J Harper; Jeffrey A Strommen; Leili S Ghahfarokhi; James C Watson; Eric J Sorenson
Journal:  Neurology       Date:  2014-08-27       Impact factor: 9.910

4.  The role of diaphragmatic thickness measurement in weaning prediction and its comparison with rapid shallow breathing index: a single-center experience.

Authors:  Lokesh Kumar Lalwani; Manjunath B Govindagoudar; Pawan Kumar Singh; Mukesh Sharma; Dhruva Chaudhry
Journal:  Acute Crit Care       Date:  2022-07-25

5.  Ultrasonographic postoperative evaluation of diaphragm function of patients with congenital heart defects.

Authors:  Erkut Öztürk; İbrahim Cansaran Tanıdır; Okan Yıldız; Bekir Yükçü; Servet Ergün; Sertaç Haydın; Alper Güzeltaş
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-01-23       Impact factor: 0.332

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.